MARKET

AMPH

AMPH

Amphastar Pharms
NASDAQ

Real-time Quotes | Nasdaq Last Sale

14.25
-0.59
-3.98%
After Hours: 14.25 0 0.00% 16:46 04/01 EDT
OPEN
14.32
PREV CLOSE
14.84
HIGH
14.72
LOW
14.06
VOLUME
234.79K
TURNOVER
--
52 WEEK HIGH
23.06
52 WEEK LOW
12.33
MARKET CAP
658.90M
P/E (TTM)
14.55
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AMPH stock price target is 21.75 with a high estimate of 24.00 and a low estimate of 20.00.

EPS

AMPH News

More
  • Edited Transcript of AMPH earnings conference call or presentation 12-Mar-20 9:00pm GMT
  • Thomson Reuters StreetEvents · 1d ago
  • Is Amphastar Pharmaceuticals, Inc.'s (NASDAQ:AMPH) CEO Pay Justified?
  • Simply Wall St. · 3d ago
  • Zacks.com featured highlights include: Amphastar Pharmaceuticals, ConforMIS, Kirkland Lake Gold, Cubic and Cimpress
  • Zacks · 03/25 14:33
  • What Bargain Hunting? Tap 5 Stocks With Rising P/E
  • Zacks · 03/24 14:47

Industry

Pharmaceuticals
-2.46%
Pharmaceuticals & Medical Research
-2.91%

Hot Stocks

Symbol
Price
%Change

About AMPH

Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company focuses primarily on developing, manufacturing, marketing and selling generic and injectable, inhalation and intranasal products. The Company has two segments: finished pharmaceutical products and active pharmaceutical ingredients (API) products. The finished pharmaceutical products segment manufactures, markets and distributes enoxaparin, Cortrosyn, Amphadase, naloxone, lidocaine jelly, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes recombinant human insulin and porcine insulin. The Company also manufactures and sells insulin API. As of December 31, 2016, the Company manufactured and sold 19 products. As of December 31, 2016, the Company developed a portfolio of 15 generic abbreviated new drug applications (ANDAs) three generic biosimilar product candidates and six injectable and inhalation product candidates.
More

Webull offers kinds of Amphastar Pharmaceuticals Inc stock information, including NASDAQ:AMPH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AMPH stock news, and many more online research tools to help you make informed decisions.